Skip to main content
Clinical Trials/NCT05594407
NCT05594407
Recruiting
N/A

The Effect of a Regimen of Opioid Sparing Anesthesia on Postoperative Recovery

Aretaieion University Hospital1 site in 1 country60 target enrollmentAugust 1, 2022

Overview

Phase
N/A
Intervention
dexmedetomidine-ketamine-lidocaine
Conditions
Pain, Postoperative
Sponsor
Aretaieion University Hospital
Enrollment
60
Locations
1
Primary Endpoint
pain score on arrival to Post-Anesthesia Care Unit (PACU)
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

The aim of this double blind randomized study will be to investigate the effect of an opioid-free anesthesia regimen with a mixture of dexmedetomidine-lidocaine-ketamine in the same syringe versus remifentanil analgesia in lumbar spine surgery

Detailed Description

Lumbar spine surgery is associated with high pain scores and perioperative disability. Ketamine, lidocaine and dexmedetomidine have all proven but varied analgesic effects. High opioid consumption has been associated with multiple side effects. This double blind clinical trial aims to investigate the possible reduction of opioid use during lumbar spine surgery by administering ketamine, lidocaine and dexmedetomidine. Sixty patients will be randomly allocated into two groups. The control group will receive a continuous infusion of remifentanil, while the Dexmedetomidine-Ketamine-Lidocaine (DKL) group will receive a continuous infusion of ketamine, lidocaine and dexmedetomidine, during the surgery and shortly after Both infusions will be administered blindly. Fentanyl and morphine will be administered to each patient so as to maintain hemodynamic stability and pain relief. The study will eventually compare the need for bolus doses of fentanyl during the surgery and morphine shortly after in each group. Multiple hemodynamic parameters, analgesic consumption, possible side effects, patient satisfaction and the Oswestry low back pain disability questionnaire will be recorded.

Registry
clinicaltrials.gov
Start Date
August 1, 2022
End Date
August 1, 2024
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr Kassiani Theodoraki

Professor of Anesthesiology

Aretaieion University Hospital

Eligibility Criteria

Inclusion Criteria

  • Adult patents
  • American Society of Anesthesiologists (ASA) class I-III
  • elective spine surgery

Exclusion Criteria

  • body mass index (BMI) \>35 kg/m2
  • contraindications to local anesthetic administration
  • systematic use of analgesic agents preoperatively
  • chronic pain syndromes preoperatively
  • neurological or psychiatric disease on treatment
  • pregnancy
  • severe hepatic or renal disease
  • history of cardiovascular diseases/ arrhythmias/ conduction abnormalities
  • bradycardia(\<55 beats/minute)
  • drug or alcohol abuse

Arms & Interventions

dexmedetomidine-ketamine-lidocaine (DKL) group

combination of dexmedetomidine, ketamine and lidocaine in one syringe

Intervention: dexmedetomidine-ketamine-lidocaine

remifentanil group

syringe of remifentanil

Intervention: Remifentanil

Outcomes

Primary Outcomes

pain score on arrival to Post-Anesthesia Care Unit (PACU)

Time Frame: immediately postoperatively

pain score by the use of Numeric Rating Scale (NRS) on arrival to PACU, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"

pain score at discharge from Post-Anesthesia Care Unit (PACU)

Time Frame: at discharge from Post Anesthesia Care Unit (PACU), approximately 1 hour postoperatively

pain score by the use of Numeric Rating Scale (NRS) at discharge from PACU, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"

pain score 3 hours postoperatively

Time Frame: 3 hours postoperatively

pain score by the use of Numeric Rating Scale (NRS) 3 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"

pain score 6 hours postoperatively

Time Frame: 6 hours postoperatively

pain score by the use of Numeric Rating Scale (NRS) 6 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"

pain score 24 hours postoperatively

Time Frame: 24 hours postoperatively

pain score by the use of Numeric Rating Scale (NRS) 24 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"

Secondary Outcomes

  • sedation on arrival to Post-Anesthesia Care Unit(immediately postoperatively)
  • sedation at discharge from Post-Anesthesia Care (PACU) Unit(at discharge from Post Anesthesia Care Unit (PACU), approximately 1 hour postoperatively)
  • time to first request for analgesia(during stay in Post-Anesthesia Care Unit (PACU), approximately 1 hour postoperatively)
  • morphine consumption in Post-Anesthesia Care Unit (PACU)(immediately postoperatively)
  • tramadol consumption in the first 48 hours(48 hours postoperatively)
  • fentanyl requirement during surgery(intraoperatively)
  • satisfaction from postoperative analgesia(24 hours postoperatively)

Study Sites (1)

Loading locations...

Similar Trials